MarketPulse
G

$GRFS

5 articles found
2 positive
1 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Hepatic Encephalopathy Market Poised for Steady Growth as New Therapies Address Rising Disease Burden

Hepatic encephalopathy market projected to grow 1.2% annually through 2036, reaching $900M in 2025, driven by emerging therapies and increased diagnosis awareness.
GRFSBHCclinical trialsmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Canadian Advocates Demand Grifols Ban After Deaths, Pushing Public Plasma Monopoly

Health care advocates call for closing Grifols plasma facilities in Canada after two deaths in Winnipeg and multiple Health Canada compliance violations.
GRFSplasma collectionGrifols
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Pegasys Market Poised for Growth Despite DAA Competition and Tariff Headwinds

Pegasys market projected for growth via rising hepatitis B prevalence and indication expansion, though direct-acting antivirals and tariff pressures pose challenges. Asia-Pacific represents fastest-growing region.
PFERHHBYGRFSemerging marketsoncology
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Plasbumin-5 Market Poised for Strong Growth as Surgical Demand Surges

Plasbumin-5 market growth accelerates as surgical demand rises, with Grifols Therapeutics leveraging Asia-Pacific expansion and strategic partnerships for market leadership.
GRFSAsia-Pacific expansionplasma-derived therapies
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Blood Plasma Derivatives Market to Double to $104B by 2033 on Rising Disease Prevalence

Blood plasma derivatives market to double to $104B by 2033, driven by rising disease prevalence and immunoglobulin demand across developed and emerging markets.
BAYRYTAKGRFSBAXmarket growthAsia-Pacific expansion